Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Consortium to Develop Stem Cell Research Tools

NEW YORK (GenomeWeb News) – Invitrogen has signed a non-binding letter of intent to collaborate with the International Regulome Consortium on the development of stem cell research tools, the firms announced yesterday at the Biotechnology Industry Organization annual meeting in San Diego.
 
Under terms of the pact, Invitrogen will contribute unspecified services and technologies to help IRC researchers map the “genetic circuit board” that regulates how stem cells give rise to specialized cells, such as neurons.
 
The IRC was formed in 2004 with seed funding from the Government of Ontario, Canada. It currently includes 58 researchers at 34 institutions in 12 countries.
 
“Invitrogen brings tremendous expertise and strength in stem cell biology to this important international consortium,” said IRC Scientific Director Michael Rudnicki, who also is a senior scientist at the Ottawa Health Research Institute. “Without question, this participation will accelerate the IRC’s research program.”

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.